Non-small Cell Lung Caner

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Non-small Cell Lung Caner trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05363280

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC…

This trial is a Phase II trial designed to evaluate the safety and efficacy of using oral AL8326 , a multi-targeted receptor Tyrosine Kinase Inhibitor( TKI) , t…

United States80 participantsStarted 2022-11-01

Treatment: AL8326 40 mg, AL8326 60 mg

All recent trials (4 shown)

Not Yet RecruitingPhase 2

NCT07562581

A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC

Aim to evaluate the efficacy and safety of luvometinib combined with anlotinib in patients with KRAS-mutated non-small cell lung caner

China48 participantsStarted 2026-06

Treatment: luvometinib + anlotinib, luvometinib + anlotinib

Not Yet RecruitingNot Applicable

NCT07110259

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

This prospective, multicenter, randomized controlled trial aims to evaluate the clinical utility of DeepGEM, an artificial intelligence (AI)-based mutation pred…

Location not specified950 participantsStarted 2025-07-31

Treatment: DeepGEM-guided Molecular Testing and Treatment, Standard Diagnostic Pathway

Non-small Cell Lung Caner

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC…

All recent trials (4 shown)

A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC…

All recent trials (4 shown)

A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

OFA in Thoracic Surgery